BETHLEHEM, Pa.--(BUSINESS WIRE)--B. Braun Medical Inc., a global leader in innovative healthcare products and services, today announced the U. S. Food and Drug Administration (FDA) approved Cefotetan for Injection and Dextrose for Injection in the DUPLEX® Drug Delivery System. With a unique design that helps ensure accurate dosage delivery and allows for room-temperature storage, DUPLEX is now the only ready-to-use IV drug delivery system available for Cefotetan therapy in the United States.
